Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1-Reference-Cited by-同舟云学术

Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1

Published:2015-06 Issue:3 Volume:37 Page:395-399
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Emoto Chie,Fukuda Tsuyoshi,Mizuno Tomoyuki,Cox Shareen,Schniedewind Björn,Christians Uwe,Widemann Brigitte C.,Fisher Michael J.,Weiss Brian,Perentesis John,Vinks Alexander A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Rapamycin in transplantation: a review of the evidence.;Saunders;Kidney Int,2001

2. . Prognostic significance of AKTmTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.;Endo;Clin Cancer Res,2013

3. . Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.;Johansson;Mol Cancer Ther,2008

4. Plexiform neurofibromas.;Korf;Am J Med Genet,1999

5. Malignancy in neurofibromatosis type 1.;Korf;Oncologist,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consequences of differences in bio-analytical assays for the precision monitoring of immunosuppressive drugs;Therapeutic Drug Monitoring;2024

2. A Chinese Collaborative Model for Accelerating Neurofibromatosis Type 1-Associated Research;2023-01-20

3. Sirolimus treatment for tuberous sclerosis complex prior to epilepsy: Evidence from a registry-based real-world study;Seizure;2022-04

4. Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants;Therapeutic Drug Monitoring;2020-10

5. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia;International Journal of Immunopathology and Pharmacology;2020-01